Dirk de Ruysscher (D.K.M.)

Ruysscher, D. D., Wauters, E., Jendrossek, V., Filippi, A. R., Revel, M.-P., Faivre-Finn, C., Naidoo, J., Ramella, S., Guckenberger, M., Ricardi, U., Khalil, A., Schor, M., Bartolomeo, V., & Putora, P. M. (2025). Diagnosis and treatment of radiation induced pneumonitis in patients with lung cancer: An ESTRO clinical practice guideline. Radiotherapy and Oncology, 207, Article 110837. https://doi.org/10.1016/j.radonc.2025.110837

Bontempi, D., Zalay, O., Bitterman, D. S., Birkbak, N., Shyr, D., Haugg, F., Qian, J. M., Roberts, H., Perni, S., Prudente, V., Pai, S., Dekker, A., Haibe-Kains, B., Guthier, C., Balboni, T., Warren, L., Krishan, M., Kann, B. H., Swanton, C., ... Aerts, H. J. W. L. (2025). FaceAge, a deep learning system to estimate biological age from face photographs to improve prognostication: a model development and validation study. The Lancet Digital Health, Article 100870. Advance online publication. https://doi.org/10.1016/j.landig.2025.03.002

Gilmore, L. A., Willmann, J., Olaechea, S., Gilmore, B. W., Dee, E. C., Rao, M., Gannavarapu, B. S., Venkateswaran, S., Alvarez, C. M., Ahn, C., de Ruysscher, D. K. M., Shah, U. A., Iyengar, N. M., Gomez, D. R., Infante, R., & Iyengar, P. (2025). Prevalence and Development of Cachexia Before and After Diagnosis of Non-small Cell Lung Cancer. American Journal of Clinical Oncology-Cancer Clinical Trials, Article 1211. Advance online publication. https://doi.org/10.1097/COC.0000000000001211

Farazi, M., Yang, X., Gehl, C. J., Barnett, G. C., Burnet, N. G., Chang-Claude, J., Parker, C. C., Dunning, A. M., Azria, D., Choudhury, A., Rancati, T., De Ruysscher, D., Seibold, P., Sperk, E., Talbot, C. J., Veldeman, L., Webb, A. J., Elliott, R., Aguado-Barrera, M. E., ... Kerns, S. (2025). A Polygenic Risk Score for Late Bladder Toxicity Following Radiotherapy for Non-Metastatic Prostate Cancer. Cancer Epidemiology Biomarkers & Prevention, 34(5), 795-804. https://doi.org/10.1158/1055-9965.EPI-24-1228

Mcwilliam, A., Marshall, D., Kerns, S. L., Barnett, G. C., Vega, A., Kapouranis, T., Aguado Barrera, M. E., Avuzzi, B., Azria, D., Chang-Claude, J., Choudhury, A., Coedo Costa, C., Dunning, A., Farcy-Jacquet, M.-P., Faivre-Finn, C., Gutiérrez-Enríquez, S., Fuentes Río, O., Gómez Caamaño, A., Lambrecht, M., ... REQUITE consortium (2025). Association of radiation-induced normal tissue toxicity with a high genetic risk for rheumatoid arthritis. Journal of the National Cancer Institute, 117(5), 1018-1026. https://doi.org/10.1093/jnci/djae349

Vaes, R. D. W., Cortiula, F., Lyu, S., Hiltermann, T. J. N., Houben, R., Degens, J., Hendriks, L. E. L., & Ruysscher, D. D. (2025). Chemoradiotherapy efficacy in patients with stage III non-small cell lung cancer (NSCLC): A prognostic clinical and biomarker-based model. Lung Cancer, 203, Article 108541. https://doi.org/10.1016/j.lungcan.2025.108541

Zhang, X., Peeters, S., Huysmans, S., Houben, R., Marcuse, F., Hochstenbag, M., & De Ruysscher, D. (2025). Risk factors and prognostic factors of pleural metastases in thymic epithelial tumors: A narrative review. European Journal of Surgical Oncology, 51(5), Article 109639. https://doi.org/10.1016/j.ejso.2025.109639

Sugden, B. M., Witlox, W. J. A., Ramaekers, B. L. T., Hattu, D., Vluggen, B., van Loon, J., Jacobs, M., Joore, M. A., & De Ruysscher, D. K. M. (2025). Adaptable framework for cost-analyses in radiotherapy: Application to the cost of proton versus photon therapy for lung cancer in The Netherlands. Radiotherapy and Oncology, 206, Article 110832. https://doi.org/10.1016/j.radonc.2025.110832

van Aken, E. S. M., Devnani, B., Castelo-Branco, L., Ruysscher, D. D., Martins-Branco, D., Marijnen, C. A. M., Muoio, B., Belka, C., Lordick, F., Kroeze, S., Pentheroudakis, G., Trapani, D., Ricardi, U., Gandhi, A. K., Prelaj, A., O'Cathail, S. M., & de Jong, M. C. (2025). ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy. Radiotherapy and Oncology, 208, Article 110910. Advance online publication. https://doi.org/10.1016/j.radonc.2025.110910

Zhang, Z., Luo, T., Yan, M., Shen, H., Tao, K., Zeng, J., Yuan, J., Fang, M., Zheng, J., Bermejo, I., Dekker, A., Ruysscher, D. D., Wee, L., Zhang, W., Jiang, Y., & Ji, Y. (2025). Voxel-level radiomics and deep learning for predicting pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant immunotherapy and chemotherapy. Journal for ImmunoTherapy of Cancer, 13(3), Article e011149. https://doi.org/10.1136/jitc-2024-011149